Prospects of GLP-1 Therapies for Addiction and Mental Health ComorbiditiesQuo Vadis
This has been investigated in 708 T2DM patients, mean age 57 years-old, 66% women, with a mean duration of diabetes of 7 years attending a diabetes conference in several cities in USA
Glucagon-Like Peptide-1 agonists, more commonly known as GLP-1 medications, were originally developed to help regulate blood sugar in people with type 2 diabetes
While GLP-1s may help with: Swelling Inflammation Pain Mobility Energy Overall wellbeing We dont know if the Lipedema adipose tissue is having the same changes as non diseased tissue as of yet
Word-of-Mouth and Patient Satisfaction Patient testimonials consistently cite MEDVis ease of use, responsive support, and high satisfaction with treatment outcomes
Semaglutide is the main (or active) ingredient in weight loss drugs like Wegovy